Clinical Trials Logo

Filter by:
NCT ID: NCT05623267 Recruiting - Clinical trials for Limited Stage Small Cell Lung Cancer

Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT

SURPASS
Start date: July 1, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study was to evaluate the efficacy of sugemalimab consolidation therapy versus placebo in patients with LS-SCLC who had not progressed following Concurrent or Sequential Chemoradiotherapy.

NCT ID: NCT05623124 Recruiting - Dementia Clinical Trials

Ruijin Neurobank of Alzheimer's Disease and Dementia

RJNB-AD
Start date: November 22, 2021
Phase:
Study type: Observational

The goal of this observational study is to learn about neuroimage and biomarkers in the Alzheimer's continuum. The main questions it aims to answer are: - How is the neurovascular coupling during AD pathogenesis? - How is the pattern/mapping of alterations in AD biomarkers? Participants will be observed and visit the research center annually to perform multi-modal MRI, PET, neuropsychological tests, and blood tests.

NCT ID: NCT05623033 Recruiting - Infections Clinical Trials

The Predictive Value of Dynamic Changes of CD4+T Lymphocytes in Primary Nephrotic Syndrome With Infection

Start date: November 16, 2022
Phase:
Study type: Observational

The goal of this observational study is to test whether the dynamic changes of CD4+T lymphocytes can predict infections in patients with primary nephrotic syndrome . The main questions it aims to answer are: - whether the dynamic changes of CD4+T lymphocytes can predict infections in patients with primary nephrotic syndrome - effect of different immunosuppressive therapy on the number and function of T lymphocyte subsets in patients with primary nephrotic syndrome Participants will be divided into infection group and non-infection group according to whether they are infected

NCT ID: NCT05622890 Recruiting - Clinical trials for Fallopian Tube Cancer

A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer

Start date: August 18, 2022
Phase: Phase 3
Study type: Interventional

This Phase III single-arm study is to evaluate the efficacy and safety of IMGN853 in Chinese adult patients with platinum-resistant high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers (hereafter referred to as PROC) with high FRα expression.

NCT ID: NCT05622864 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Study on Single and Multiple Atomization Inhalation of HRS-9821 Suspension for Inhalation in Healthy Subjects

Start date: January 12, 2023
Phase: Phase 1
Study type: Interventional

The increased safety and tolerance of single and multiple atomized inhalation of HRS-9821 suspension for inhalation doses in healthy subjects.

NCT ID: NCT05622656 Recruiting - Pain, Postoperative Clinical Trials

Dexmedetomidine Reduce Postoperative Pain of C-section

Start date: December 1, 2022
Phase: Phase 4
Study type: Interventional

The purpose of this study was to make sure whether the infiltration of dexmedetomidine around the uterus can reduce the pain of cesarean section surgery.Studies have shown that the use of local anesthetic infiltration around the uterus can reduce pain after cesarean section surgery.In observed group, 50ug of dexmedetomidine (volume 10ml) was infiltrated around the uterus at the end of the caesarean section, while in controled group, 10ml normal saline as placebo was infiltrated around the uterus. VASs was accessed in 2h 12h,24h,48h after surgery.

NCT ID: NCT05622565 Recruiting - Image, Body Clinical Trials

Explainable Ocular Fundus Diseases Report Generation System

Start date: January 2011
Phase:
Study type: Observational

To establish a deep learning system of various ocular fundus disease analytics based on the results of multimodal examination images. The system can analyze multimodal ocular fundus images, make diagnoses and generate corresponding reports.

NCT ID: NCT05622552 Recruiting - Manic Episode Clinical Trials

Effect of tDCS Combined With Pharmacological Treatments for Bipolar Mania

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to conduct a randomized double-blind controlled trial to explore the efficacy and safety of transcranial direct current stimulation (tDCS) in the treatment of manic episode (ME) and analyzes the brain functional connectivity to construct the therapeutic effect prediction model of tDCS for ME. The main questions it aims to answer are: - A randomized double-blind controlled trial is conducted to clarify the efficacy and safety of tDCS combined with pharmacological treatments in the ME. - A therapeutic effect prediction model of tDCS for ME by using functional near-infrared spectroscopy to evaluate brain function. Participants will be receive: - clinical data interview and clinical symptom assessment. - the functional near-infrared spectroscopy (fNIRS) to analysis brain functional connectivity. - tDCS stimulation, which was performed once a day sessions of active or sham anodal tDCS to the right dorsolateral prefrontal cortex and Cathode to the left OFC (2 mA, 20 minutes, 10 sessions). In the active group, current stimulations were gradually ramped up to 2 mA (in 30 seconds) intensity for 20 minutes, once a day, for 10 days. For sham stimulation, the procedure was identical, except that the current was gradually ramped up to 2mA and rapidly down to zero (in 30 seconds), thus leading to the same initial sensations of tDCS.

NCT ID: NCT05622266 Recruiting - Clinical trials for Irreversible Pulpitis

Effectiveness of Pulpotomy in the Management of Mature Permanent Tooth With Irreversible Pulpits

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

This study is to evaluate the effectiveness of pulpotomy in mature permanent tooth with irreversible pulpits, and compare the clinical efficacy of pulpotomy and root canal therapy.

NCT ID: NCT05622240 Recruiting - Breast Cancer Clinical Trials

99mTc-MIRC213 SPECT/CT for the Detection of HER2-positive Breast Cancer

Start date: September 7, 2022
Phase: Early Phase 1
Study type: Interventional

This is an open-label single photon emission tomography/computed tomography (SPECT/CT) study to investigate the imaging performance of 99mTc-MIRC213 in breast cancer patients. A single dose of 11.1-14.8Mega-Becquerel (MBq) per kilogram body weight 99mTc-MIRC213 will be injected intravenously. Visual and semiquantitative method will be used to assess the SPECT/CT images.